Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
Access all of the press releases and statements related to the work of the Vaccine Alliance
11 October 2016
Girl Effect and Gavi join forces with US$ 10 million commitment to fight cervical cancer in developing world
5 October 2016
Gavi welcomes contribution of US$ 25 million from the Kingdom of Saudi Arabia
21 September 2016
Gavi and Philips team up to improve immunisation data quality in developing countries
27 July 2016
Sudan: first to introduce life-saving meningitis A vaccine into routine immunization
30 June 2016
Gavi Board reappoints WHO's Flavia Bustreo as vice-chair
23 June 2016
Gavi Board makes decisions on malaria vaccine pilots, health systems, and supply and procurement strategy
26 May 2016
Gavi welcomes contribution of US$ 76 million from Government of Japan
Gavi welcomes price trend for pentavalent vaccine
23 May 2016
World Humanitarian Summit - Gavi's Fragility and Immunisation Policy
22 April 2016
Gavi tackling environmental challenges head on
7 April 2016
Norway strengthens commitment to immunisation in developing countries
17 March 2016
Gavi welcomes new record low price for pneumococcal vaccine